Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Kuros Biosciences Ltd.
DescriptionBacterially-produced subunit vaccine consisting of the globular domain of the influenza A hemagglutinin surface protein coupled to the virus-like particle Qbeta
Molecular Target Influenza A virus hemagglutinin (HA)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationInfluenza virus
Indication DetailsVaccinate against influenza virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today